In 40 adults with uncontrolled asthma randomised to azithromycin or placebo for 12 weeks, rhinovirus-induced IFN-β and IFN-λ rose from baseline in epithelial cells in the azithromycin group (n=16) but not placebo (n=16); clinical outcomes did not differ significantly.
RCTn = 40
Ghanizada et al. Azithromycin enhances epithelial antiviral immunity in uncontrolled asthma: results from the AZIMUNE randomised controlled trial